ArticleDrug delivery2022
Legumain/pH dual-responsive lytic peptide-paclitaxel conjugate for synergistic cancer therapy.
Shanshan Zheng et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
9 papers cite it
this papercites it
ArticleDrug delivery2022
Shanshan Zheng et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.